Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06510231

Inspiratory Muscle Training in HFpEF

Led by Mayo Clinic · Updated on 2025-10-20

68

Participants Needed

1

Research Sites

181 weeks

Total Duration

On this page

Sponsors

M

Mayo Clinic

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is being done to determine how inspiratory muscle training impacts inspiratory muscle function during exercise in heart failure patients.

CONDITIONS

Official Title

Inspiratory Muscle Training in HFpEF

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Receiving SGLT2 inhibitors and spironolactone (and beta-blocker use for HFpEF patients with hypertension) for more than 3 months
  • NYHA symptoms I-III
  • Body mass index 40 kg/m2 or less
  • Currently non-smokers with less than 20 pack-year smoking history
  • Able to exercise without significant orthopedic or musculoskeletal limitations
Not Eligible

You will not qualify if you...

  • Ventricular tachycardia and/or ventricular fibrillation within 21 days of visit 1
  • Second or third degree heart block
  • Body mass index over 40 kg/m2
  • Current smokers or smoking history over 20 pack years
  • Pregnant women
  • Glomerular filtration rate less than 30 mL/min/1.73m2
  • Unable to engage in exercise
  • Uremia or history of allergy to iodides
  • Peripheral artery disease
  • Alanine transaminase and/or aspartate transaminase levels greater than twice the upper limit of normal
  • Asthmatic patients with low symptom perception or severe exacerbations
  • Ruptured eardrum or other ear conditions
  • History of spontaneous pneumothorax or osteoporosis with rib fractures
  • History of lidocaine allergy
  • Additional exclusions for DEXA scanning participants: recent gastrointestinal contrast or radionuclide administration, severe degenerative changes or fractures in measurement areas, or inability to remain motionless during measurement

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

E

Eric Bruhn, M.A.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here